Patent · US Active

Alpha 1-antitrypsin compositions and methods of making and using same

US8557961B2 · kind B2 · utility

14Cited by
6References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2011
Grant dateOct 15, 2013
Priority date
Expiry dateNov 11, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/74
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising alpha 1-antitrypsin linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in the treatment of alpha 1-antitrypsin-related diseases, disorders, and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.